Browsing by Subject "drug cost"

Now showing items 1-3 of 3

Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: Dosing patterns and related costs in Switzerland from a payers perspective

Zeidler, Jan; Mittendorf, Thomas; Müller, Rüdiger; Kempis, Johannes von (Heidelberg : Springer Verlag, 2012)

Background: To obtain detailed real-life data on costs and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in patients treated in Switzerland. Methods: Administrative claims ...
Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia

Plagemann, Thomas; Prenzler, Anne; Mittendorf, Thomas (Heidelberg : Springer Verlag, 2011)

Because of an elevated serum phosphate level, patients who suffer from chronic kidney failure frequently tend to have cardiovascular calcification and are therefore exposed to a higher probability of a fatal event. Phosphate ...
A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

Lange, Ansgar; Prenzler, Anne; Frank, Martin; Golpon, Heiko; Welte, Tobias; Schulenburg, Johann-Matthias Graf von der (London : BioMed Central Ltd., 2014)

Background: Non-small cell lung cancer (NSCLC) imposes a substantial burden on patients, health care systems and society due to increasing incidence and poor survival rates. In recent years, advances in the treatment of ...

Now showing items 1-3 of 3

Browse